Browse Tag

neuromodulation

Boston Scientific Stock Rockets on Blowout Q3 Results and Major Medical Wins

Boston Scientific (BSX) Stock Today: Price Slips as Neuromodulation Bull Case, Epic EHR Deal and Big Fund Moves Shape the Outlook – November 19, 2025

Boston Scientific Corporation (NYSE: BSX) shares traded lower on Wednesday, November 19, 2025, even as a wave of fresh research, strategic partnership news and institutional ownership updates painted a largely constructive long‑term picture for the medtech giant. BSX stock price on 19 November 2025 As of late Wednesday trading, Boston Scientific stock was changing hands at around $96.6, down roughly 2.6% on the day. Intraday, BSX has traded in a range of roughly $96–$100, with volume running in the high single‑digit millions of shares. Investing.com Recent price action shows a short losing streak: BSX closed at about $99.2 on Tuesday
Go toTop